Relay Therapeutics (RLAY) Shares Issued (2019 - 2024)
Relay Therapeutics (RLAY) reported Shares Issued of $218.2 million for Q3 2024, up 2221.28% year-over-year from $9.4 million in Q4 2023, and up 1118.99% on a QoQ basis from $17.9 million in Q1 2024.
Relay Therapeutics (RLAY) has 6 years of Shares Issued data on file, last reported at $218.2 million in Q3 2024.
- Quarterly Shares Issued rose 2221.28% year-over-year to $218.2 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $246.0 million (down 16.74% YoY) and the FY2024 annual result came in at $17.9 million, down 40.92% from the prior year.
- Shares Issued improved to $218.2 million in Q3 2024 per RLAY's latest filing, from $17.9 million in the prior quarter.
- Across five years, Shares Issued topped out at $427.1 million in Q3 2020 and bottomed at -$426.6 million in Q4 2020.
- The 5-year median for Shares Issued is $902000.0 (2021), against an average of $35.7 million.
- Peak annual rise in Shares Issued reached 355801.67% in 2020, while the deepest fall reached 96831.07% in 2020.
- Tracing RLAY's Shares Issued over 5 years: stood at -$426.6 million in 2020, then surged by 99.31% to -$2.9 million in 2021, then surged by 118.69% to $549000.0 in 2022, then surged by 1612.2% to $9.4 million in 2023, then soared by 2221.28% to $218.2 million in 2024.
- Per Business Quant, the three latest RLAY Shares Issued figures stand at $218.2 million (Q3 2024), $17.9 million (Q1 2024), and $9.4 million (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Relay Therapeutics | 2.53 Bn | 2.53 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 218.20 Mn |
| Sep 30, 2024 | 218.20 Mn |
| Mar 31, 2024 | 17.90 Mn |
| Mar 31, 2024 | 17.90 Mn |
| Sep 30, 2023 | 9.40 Mn |
| Sep 30, 2023 | 9.40 Mn |
| Dec 31, 2022 | 549,000.00 |
| Dec 31, 2022 | 549,000.00 |
| Sep 30, 2022 | 284.70 Mn |
| Sep 30, 2022 | 284.70 Mn |
| Jun 30, 2022 | 859,000.00 |
| Jun 30, 2022 | 859,000.00 |
| Mar 31, 2022 | 883,000.00 |
| Mar 31, 2022 | 883,000.00 |
| Dec 31, 2021 | -2.94 Mn |
| Dec 31, 2021 | -2.94 Mn |
| Sep 30, 2021 | 902,000.00 |
| Sep 30, 2021 | 902,000.00 |
| Jun 30, 2021 | 1.12 Mn |
| Jun 30, 2021 | 1.12 Mn |
| Mar 31, 2021 | 2.06 Mn |
| Mar 31, 2021 | 2.06 Mn |
| Dec 31, 2020 | -426.58 Mn |
| Dec 31, 2020 | -426.58 Mn |
| Sep 30, 2020 | 427.08 Mn |
| Sep 30, 2020 | 427.08 Mn |
| Jun 30, 2020 | 367,000.00 |
| Jun 30, 2020 | 367,000.00 |
| Mar 31, 2020 | 351,000.00 |
| Mar 31, 2020 | 351,000.00 |
| Dec 31, 2019 | 441,000.00 |
| Dec 31, 2019 | 441,000.00 |
| Sep 30, 2019 | 120,000.00 |
| Sep 30, 2019 | 120,000.00 |